Table Of Content

Contents of Volume 142 - 1999 Abel KM, Cleare AJ: Peripheral hormonal Cools AR — Bruin NMWJ de Gigerenzer G > Ehrenreich H responses to D-fenfluramine as a probe Corwin J —> Potter A Girardon S > Millan MJ of central serotonergic function in hu- Cutrell EB — Davidson MC Glode BM — Burk JA mans 68 Gnys M — Hutchison KE Ahlenius S — Uvniis-Moberg K Daniels S + Renshaw PF Goeders NE — Mantsch JR Ahtee L — Honkanen A Davidson MC, Cutrell EB, Marrocco RT Goldberg SR — Shoaib M Alguacil LF — Pérez-Garcia C Scopolamine slows the orienting of at- Goudie AJ, Smith JA, Robertson A, Cava Allen RM, Dykstra LA: The competitive tention in primates to cued visual targets nagh C: Clozapine as a drug of depen NMDA receptor antagonist LY235959 dence 369 modulates the progression of morphine De Vries TJ — Nestby P Gouzoulis-Mayfrank E, Thelen B, Haber- tolerance in rats 209 De Vry J — West MW meyer E, Kunert HJ, Kovar K-A, Amit Z — Smith BR Dekeyne A — Millan MJ Lindenblatt H, Hermle L, Spitzer M, Andres P — Mancuso G Demling J — Sperling W Sass H: Psychopathological, neuroendo Ansseau M — Mancuso G Depoortere R, Perrault G, Sanger DJ: In- crine and autonomic effects of 3,4-me tracranial self-stimulation under a pro- thylenedioxyethylamphetamine (MDE), Baker GB — Parent MB gressive-ratio schedule in rats: effects of psilocybin and d-methamphetamine in Barocka A — Sperling W strength of stimulation, d-amphetamine, healthy volunteers. Results of an experi- Barocka A — Thuerauf N 7-OH-DPAT and haloperidol 221 mental double-blind placebo-controlled Bauer B — Evers S Détari L, Szentgy6rgyi V, Hajnik T, Széna- study 41 Beck AM — Khroyan TV si G, Gacsalyi I, Kukorelli T: Differen- Granados R — Colado MI Biggs TAG — West MW tial EEG effects of the anxiolytic drugs, Green AR — Colado MI Bjork JM, Dougherty DM, Moeller FG, deramciclane (EGIS-3886), ritanserin Groff RS — Khroyan TV Cherek DR, Swann AC: The effects of and chlordiazepoxide in rats 318 Grotemeyer K-H — Evers S tryptophan depletion and loading on lab Dietz R — Thuerauf N oratory aggression in men: time course Dougherty DM — Bjork JM Habermeyer E — Gouzoulis-Mayfrank E and a food-restricted control 24 Drugan RC — Burk JA Habib MK — Parent MB Bjorkstrand E — Uvniis-Moberg K Dykstra LA > Allen RM Hajnik T > Détari L Brandao ML — Pandossio JE Harmer CJ, Phillips GD: Enhanced condi- Britton DR — Pearce RKB Ehrenreich H, Rinn T, Kunert HJ, Moeller tioned inhibition following repeated pre- Bruin NMW/]J de, Ellenbroek BA, Cools MR, Poser W, Schilling L, Gigerenzer treatment with d-amphetamine 120 AR, Coenen AML, Luijtelaar ELJM van: G, Hoehe MR: Specific attentional dys- Hermle L — Gouzoulis-Mayfrank E Differential effects of ketamine on gat- function in adults following early start of Hillegaart V — Uvniis-Moberg K ing of auditory evoked potentials and cannabis use 295 Hoehe MR — Ehrenreich H prepulse inhibition in rats 9 Ellenbroek BA — Bruin NMWJ de Homberg JR — Nestby P Burk JA, Glode BM, Drugan RC, Mair Ellinwood EH Jr — King GR Honkanen A, Mikkola J, Korpi ER, Hyytié RG: Effects of chlordiazepoxide and FG Ellison GD — Martinez ZA P, Seppala T, Ahtee L: Enhanced mor- 7142 on a rat model of diencephalic am- Elsworth JD — Jentsch JD phine- and cocaine-induced behavioral nesia as measured by delayed-matching- Emrich HM — Leweke FM sensitization in alcohol-preferring AA to-sample performance 413 Engel JA — Olausson P rats 244 Esteban B — Colado MI Horan JT — Smith BR Cano MV — Pérez-Garcia C Evers S, Schmidt F, Bauer B, Voss H, Horger BA — Taylor JR Catapano D > Sinha R Grotemeyer K-H, Husstedt [W: The im- Horiguchi J - Okamoto Y Cavanagh C — Goudie AJ pact of ergotamine-induced headache Houtsmuller EJ, Stitzer ML: Manipulation Cherek DR, Moeller FG, Khan-Dawood F, and ergotamine withdrawal on informa- of cigarette craving through rapid smok- Swann A, Lane SD: Prolactin response tion processing 61 ing: efficacy and effects on smoking be- to buspirone was reduced in violent havior 149 compared to nonviolent parolees 144 Fiorino DF, Phillips AG: Facilitation ot Husstedt IW — Evers S Cherek DR — Bjork JM sexual behavior in male rats following d- Hutchison KE, Monti PM, Rohsenow DJ, Chiu HFK — Ungvari GS amphetamine-induced behavioral sensiti- Swift RM, Colby SM, Gnys M, Niaura Chow LY — Ungvari GS zation 200 RS, Sirota AD: Effects of naltrexone Clark E Jr — Tizabi Y FiSerova M, Consolo S, Krsiak M: Chronic with nicotine replacement on smoking Cleare AJ — Abel KM morphine induces long-lasting changes cue reactivity: preliminary results 139 Coenen AML — Bruin NMWJ de in acetylcholine release in rat nucleus Hyytii P - Honkanen A Cohen C, Perrault G, Sanger DJ: Effects of accumbens core and shell: an in vivo mi- D, dopamine receptor agonists on oral crodialysis study 85 Jackson M — Pearce RKB ethanol self-administration in rats: com- Fletcher PJ, Korth KM: Activation of 5- Janowsky DS — Tizabi Y parison with their efficacy to produce HT), receptors in the nucleus accumbens Jenner P + Pearce RKB grooming and hyperactivity 102 reduces amphetamine-induced enhance- Jentsch JD, Taylor JR, Redmond DE Jr, Colado MI, Esteban B, O’ Shea E, Grana- ment of responding for conditioned re- Elsworth JD, Youngren KD, Roth RH dos R, Green AR: Studies on the neuro- ward 165 Dopamine D, receptor antagonist rever- protective effect of pentobarbitone on Fonte C — Perkins KA sal of subchronic phencyclidine-induced MDMA- induced neurodegeneration Fuchs RA —> Khroyan TV object retrieval/detour deficits in mon- 421 keys 78 Colby SM — Hutchison KE Gacsalyi | — Détari L Cole JC, Littleton JM, Little HJ: Effects of Gallate JE, McGregor IS: The motivation Kaegler M —> Thuerauf N repeated ethanol administration in the for beer in rats: effects of ritanserin, nal- Kagaya A — Okamoto Y plus maze; a simple model for condi- oxone and SR 141716 302 Khan-Dawood F — Cherek DR tioned abstinence behaviour 270 Gaskin S > Smith BR Khansefid N — Sabetkasai M Consolo S — FiSerova M Geyer MA — Martinez ZA Khroyan TV, Fuchs RA, Beck AM, Groff IV RS. Neisewander JL: Behavioral interac Miinte TF — Leweke FM pendent subjects: a preliminary report tions produced by co-administration of Myers RD > West MW 132 7-OH-DPAT with cocaine or apomor- Rezvani AH — Tizabi Y phine in the rat 383 Neisewander JL — Khroyan T\ Rinn T —> Ehrenreich H King GR, Xiong Z, Ellinwood EH Ji Nestby P, Schoffelmeer ANM, Homberg Robertson A — Goudie AJ Withdrawal from continuous cocaine ad JR, Wardeh G, De Vries TJ, Mulder AH, Rogers V — Renshaw PF ministration: time dependent changes in Vanderschuren LJMJ: Bremazocine re- Rohsenow DJ — Hutchison KE accumbens 5-HT, receptor function and duces unrestricted free-choice ethanol Roth RH — Jentsch JD behavioral tolerance 352 self-administration in rats without affect- Kling MA — Tizabi Y ing sucrose preference 309 Sabetkasai M, Khansefid N, Yahyavi S-H, Kobal G — Thuerauf N Newhouse PA — Potter A Zarrindast MR: Baclofen and antidepres- Korpi ER — Honkanen A Niaura RS — Hutchison KE sant — induced antinociception in forma- Korth KM — Fletcher PJ Ninan I, Kulkarni SK: Differential effects lin test: possible GABA, mechanism in- Kovar K-A —G ouzoulis-Mayfrank E of olanzapine at dopamine D, and D, re- volvement 426 Krsiak M — FiSerova M ceptors in dopamine depleted animals Sancho I — Pérez-Garcia C Kuczenski R — Segal DS 175 Sanders M — Perkins KA Kukorelli T — Détari | Sanger DJ — Cohen C Kulkarni SK — Ninan | Okamoto Y, Okamoto Y, Kagaya A, Ho- Sanger DJ — Depoortere R Kunert HJ — Ehrenreich H riguchi J, Yamawaki S: The relationship Sass H — Gouzoulis-Mayfrank E Kunert HJ — Gouzoulis-Mayfrank | of the platelet 5-HT-induced calcium re- Schilling L — Ehrenreich H sponse to clinical symptoms in eating Schmidt F — Evers S ane SD >» Cherek DR disorders 289 Schneider U — Leweke FM ang J > Potter A Okamoto Y — Okamoto Y Schoffelmeer ANM — Nestby P au BST — Ungvari GS Olausson P, Engel JA, S6derpalm B: Be- Schreiber R — West MW enox R — Potter A havioral sensitization to nicotine is asso- Segal DS, Kuczenski R: Escalating dose- eweke FM, Schneider | . Thies M, Miinte ciated with behavioral disinhibition; binge stimulant exposure: relationship IF, Emrich HM: Effects of synthetic A’- counteraction by citalopram 111 between emergent behavioral profile tetrahydrocannabinol on binocular depth O’ Malley S —> Sinha R and differential caudate-putamen and inversion of natural and artificial objects O’Shea E — Colado MI nucleus accumbens dopamine responses inman 230 Overstreet DH — Tizabi Y 182 indenblatt H — Gouzoulis-Mayfrank E Seppala T — Honkanen A ittle HJ — Cole JC Pandossio JE, Brandao ML: Defensive re- Shiosaki K — Pearce RKB ittleton JM — Cole JC actions are counteracted by midazolam Shoaib M, Swanner LS, Yasar S, Goldberg ouis VA — Tizabi Y and muscimol and elicited by activation SR: Chronic caffeine exposure potentia- uijtelaar ELJM van — Bruin NMWJ de of glutamate receptors in the inferior tes nicotine self-administration in rats ukas SE — Renshaw PI colliculus of rats 360 .3 47 undahl LH — Renshaw PI Parent MB, Habib MK, Baker GB: Task- Sinha R, Catapano D, O’ Malley S: Stress- dependent effects of the antidepres- induced craving and stress response in Mair RG — Burk JA sant/antipanic drug phenelzine on mem- cocaine dependent individuals 343 Man MS — McAliister-Williams RH ory 280 Sirota AD — Hutchison KE MancusoG , Andres P, Ansseau M, Tirelli Pearce RKB, Jackson M, Britton DR, Shio- Smith BR, Horan JT, Gaskin S, Amit Z E: Effects of nicotine administered via a saki K, Jenner P, Marsden CD: Actions Exposure to nicotine enhances acquisi- transdermal delivery system on vig!- of the D, agonists A-77636 and A-86929 tion of ethanol drinking by laboratory lance: a repeated measure study 18 on locomotion and dyskinesia in MPTP- rats in a limited access paradigm 408 Mantsch JR, Goeders NE: Ketoconazole treated L-dopa-primed common marmo- Smith JA — Goudie AJ blocks the stress-induced reinstatement sets 5] Séderpalm B — Olausson P of cocaine-seeking behavior in rats: rela- Pérez-Garcia C, Morales L, Cano MV, Sperling W, Vieth J, Martus M, Demling J, tionship to the discriminative stimulus Sancho |, Alguacil LF: Effects of hista- Barocka A: Spontaneous slow and fast effects of cocaine 399 mine H, receptor ligands in experimental MEG activity in male schizophrenics Marrocco RT — Davidson MC models of anxiety and depression 215 treated with clozapine 375 Marsden CD > Pearce RKB Perkins KA, Sanders M, Fonte C, Wilson Spitzer M — Gouzoulis-Mayfrank I Martinez ZA, Ellison GD, Geyer MA, AS, White W, Stiller R, McNamara D Stiller R — Perkins KA Swerdlow NR: Effects of sustained co- Effects of central and peripheral nicotin- Stitzer ML — Houtsmuller EJ caine exposure on sensorimotor gating ic blockade on human nicotine discrimi- Swann A — Cherek DR of startle in rats 253 nation 158 Swann AC — Bjork JM Martus M — Sperling W Perrault G — Cohen C Swanner LS — Shoaib M McAllister-Williams RH, Man MS, Young Perrault G + Depoortere R Swerdlow NR — Martinez ZA AH: Effects of adrenalectomy on 8-OH- Phillips AG — Fiorino DF Swift RM — Hutchison KE DPAT induced hypothermia in mice 73 Phillips GD — Harmer CJ Szénasi G — Détari L McGregor IS — Gallate JI Piasecki M — Potter A Szentgy6rgyi V — Détari L McNamara D — Perkins KA Poser W — Ehrenreich H Mikkola J — Honkanen A Potter A, Corwin J, Lang J, Piasecki M, Tang WK — Ungvari GS Millan MJ, Girardon S, Dekeyne A Lenox R, Newhouse PA: Acute effects of laylor JR, Horger BA: Enhanced respond- 5-HT>¢ receptors are involved in the dis the selective cholinergic channel activa- ing for conditioned reward produced criminative stimulus effects of citalo tor (nicotinic agonist) ABT-418 in Alz- by intra-accumbens amphetamine is pram inrats 432 heimer’s disease 334 potentiated after cocaine sensitization Moeller FG — Bjork JM 3] Moeller FG — Cherek DR Redmond DE Jr — Jentsch JD Taylor JR — Jentsch JD Moeller MR — Ehrenreich H Renshaw PF, Daniels S, Lundahl LH, Rog lhelen B — Gouzoulis-Mayfrank E Monti PM — Hutchison KE ers V, Lukas SE: Short-term treatment Thies M — Leweke FM Morales L — Pérez-Garcia C with citicoline (CDP-choline) attenuates Thuerauf N, Kaegler M, Dietz R, Barocka Mulder AH — Nestby P some measures of crav Ing in cocaine de A, Kobal G: Dose-dependent stereose- lective activation of the trigeminal sen- mediator of SSRI-induced antidepressant Xiong Z > King GR sory system by nicotine in man 236 effects 95 Tirelli E— Mancuso G Yahyavi S-H — Sabetkasai M Tizabi Y, Overstreet DH, Rezvani AH, Vanderschuren LJMJ — Nestby P Yamawaki S — Okamoto Y Louis VA, Clark E Jr, Janowsky DS, Vieth J — Sperling W Yasar S — Shoaib M Kling MA: Antidepressant effects of nic- Voss H > Evers S Young AH — McAllister-Williams RH otine in an animal modei of depression Youngren KD — Jentsch JD 193 Wardeh G — Nestby P West MW, Biggs TAG, Schreiber R, De Zarrindast MR — Sabetkasai M Ungvari GS, Chiu HFK, Chow LY, Lau Vry J, Myers RD: Calcium channel ago- BST, Tang WK: Lorazepam for chronic nist (—)-BAY k 8644 suppresses free and catatonia: a randomized, double-blind, limited access intake of alcohol in genet- placebo-controlled cross-over study 393 ic drinking rats 261 Indexed in Current Contents Uvnis-Moberg K, Bjérkstrand E, Hillega- White W — Perkins KA Psychological Abstracts, art V, Ahlenius S: Oxytocin as a possible Wilson AS — Perkins KA Psyc INFO, Index Medicus and in EMBASI Subject index of Volume 142 - 1999 Abstinence 85 CNS effect 158 Extinction 22] ABT-418 334 Cocaine 31, 132, 244, 253, FG 7142 413 Acetylcholine 85 Cocaine abuse 343 Formalin test 426 Acute administration 383 Conditioned inhibition 120 FSL and FRL rats 193 Adrenalectomy 73 Conditioned reward 31, 165 GABA 280, 421 Aggression 24, 144 Conditioning 120, 200, 270 Genetic model of alcoholism 261 Alcohol 302 Consummatory 200 Glutamate 360 Alcohol drinking 261 Continuous cocaine 352 Grooming behavior 102 Alcohol intake 261 Corticosterone 399 Haloperidol 375 Alcohol preference 244 Cortisol 68 Headbobbing 383 \lcoholism 261 Covert orienting | HistamineH ; receptor 215 Alzheimer’s disease 334 Craving 132, 139, 149, 302, 343 5-HT 68, 73 Amphetamine 182 Cytidine 132 5-HT;, receptor 165 Amygdala 120 D, dopamine agonist 102 5-HT>, receptor 289 \nimal model of depression 193 D, receptor 78 5-HTx- 432 \ntinociception 209 DA release 352 5-HT; receptor 352 Anxiety 215,270 d-Amphetamine 9, 31, 120, 165, 200, 221 Human 24, 132, 149, 230 Appetitive 200 Dependence 369 Human performance 18 Attention | Depression 95,215 5-Hydroxytryptamine 165, 421 Attentional function 295 Deramciclane 318 Hyperthermia 42] Atypical antipsychotic 369 Desipramine 426 Hypothermia 73 Auditory evoked potentials (AEP) Development 295 Imipramine 426 Autoreceptor 383 Dexamethasone 68 Inferior colliculus 360 Aversion 360 Diencephalic amnesia 413 Information processing 61 Baclofen 426 Diet 24 Inhibitory avoidance 280 Beer 302 Dipole S4i e! 5 Intracellular calcium concentration 289 Behavioral sensitization 111,244 Discriminative stimulus 432 Ketamine 9 Behaviour 85 L-Dopa 51 Ketoconazole 399 Benzodiazepine 393 Dopamine 78, 144, 165, 182, 221, 280 Learning 280, 334 Binge 182 Dopamine agonist 51 Limited access 408 Binocular depth inversion 230 DopamineD , receptor 175 Locomotion 383 Biogenic amines 280 DopamineD , receptor 175 Locomotor activity 31, 102, 111, 244 Bremazocine 309 Dopamine D.-like receptor 383 Magnetoencephalography 375 Buspirone 144 Dopamine D, receptor 383 MDE 41 Caffeine 327 Dopamine receptor 383 Mecamylamine HCI] 408 Calcium channels 261 Dronabinol 230 Medication 132 Cannabinoids 230, 295 Drug dependent 132 Memory 78, 280, 334 Catatonia 393 Drug discrimination 158, 399, 432 Mesolimbic dopamine 200 Caudate-putamen 182 Dyskinesia 5] Methamphetamine 41, 182 CDP-choline 132 Dystonia 51 3,4-Methylenedioxymethamphetamine Chlordiazepoxide 318, 413 Eating disorders 289 421 Chorea 51 Ecstasy 41, 421 Mice 73, 426 Chronic 85 Elevated plus-maze 111 Microdialysis 85, 182 Cigarette | Entactogens 41 Midazolam 360 Citalopram li Ergotamine derivatives 61 Migraine 61 Citicoline 132 Ethanol 270, 309, 408 Monkey l Clobenpropit Ethanol self-administration 102 Morphine 85, 244 Clozapine 369, Event-related potentials 61 Motivation 200 Vi MPTP 51 Phenelzine 280 Serotonin 24, 68, 111, 144, 280, 432 Muscimol 360 Physiological response 343 Sexual behavior 200 Naloxone 302 Place conditioning 383 SKF 38393 175 Naltrexone 139, 309 Platelet 289 Slow wave sleep 318 Neurodegeneration 42] Plus maze 270 Smoking 149 Neuroendocrine 68 Prefrontal cortex 78 Smoking cue 139 Neuroprotection 42] Prepulse inhibition 253 Somatodendritic 5-HT,, receptor Neuropsychology 295 Prepulse inhibition (PPI) 9 Spatial water maze 280 Neurotoxicity 253 Primate 78 Spontaneous activity 375 Nicotine 18, 111, 149, 158, 193, 236, 408 Primates 51 SR 141716 302 Nicotine replacement patch 139 Progressive-ratio 22] SSRIs 95 Nicotine self-administration 327 Prolactin 144 Startle 253 Nicotinic antagonist 158 Psilocybin 41 Stereoisomers 236 Nicotinic receptor 193 Psychological stress 343 Stereotypy 85, 182, 383 NMDA antagonists 209 Psychopathology 41 Stress 399 NMDA (N-methyl-D-aspartate) 9 Psychotomimetic 78 Subjective effect 158 Norepinephrine 280 R-a-methylhistamine 215 Sucrose 309 Novel nicotinic agonist 334 Rapid smoking 149 Tail-withdrawal 209 Nucleus accumbens 31, 120, 165, Rat 9, 95, 221, 261, 302, 318, Temperature 369 352 369, 408, 413 THC 230 Nucleus accumbens core 85 Reaction time 1,18 Thioperamide 215 Nucleus accumbens shell 85 Reinforcement 158 Tolerance 18, 209, 352 8-OH-DPAT 73 Reinstatement 399 lransdermal delivery 18 7-OH-DPAT 221 Repeated administration Trigeminal 236 Olanzapine 175 Reward 120 Iryptophan 24 Olfaction 236 Ritanserin 302, 318 U50,488H 309 Opiate 85 Schizophrenia Urge 139 Opioid 209 Scopolamine | Ventral tegmental area 221 Oxytocin 95 Selected rat lines 244 Vigilance 18 P5O 9 Self-administration 158, 399 Violence 144 Pain 236 Self-report 149 Visual scanning 295 Parkinson's disease 5] Self-stimulation 22] Voluntary intake 408 Partial agonist 175 Sensitization 31, 120, 200 383 Withdrawal 85, 270, 369 Pentobarbitone 421 Sensory 236 Working memory | Pharmacotherapy 261 Sensory gating 9